The In Vivo Therapeutics Core (IVTC) is a state-of-the-art shared resource of the Indiana University Melvin and Bren Simon Cancer Center (IUSCC) that serves as a recognized shared resource of the Indiana University School of Medicine (IUSOM), providing cost-effective and comprehensive services including, but not limited to, on-site breeding facilities as well as a numerous in vivo pharmacology models to facilitate the development and testing of novel pharmacological &cellular therapies. It is a certified shared resource of the Indiana Clinical and Translational Sciences Institute (iCTSI). The IVTC maintains multiple mouse colonies on campus. Additionally, this shared resource offers a range of services that span from traditional xenograft services to advanced humanized mouse models of cancer, and offer the flexibility to customize studies. This includes setting up new models of disease and validating in the core. IVTC personnel are highly trained and have extensive experience in many different animal models, dose routes, and species (including transplantation, surgical, and stereotactic procedures) and equipment. The shared resource has increased in its size and now has four personnel. IVTC supports the research and development of safe and more efficacious drug treatment for IUSCC investigators, and IVTC continues to be engaged with their customers to enable the necessary research capabilities be built and validated in their quest to obtain external funding. The IVTC interacts closely with the Clinical Pharmacology Analytical Core (CPAC) and other IUSCC shared resources including the Chemical Genomics Core, and the Indiana Institute for Biological Imaging Sciences. For example, the drug discovery process should provide a delicate balance between the chemistry, pharmacology, and pharmacokinetics of the drug. Over the past few years, CPAC and IVTC have worked together to generate data that allow PIs to better evaluate molecules being developed within the IUSCC that show promise as novel cancer drugs. The IVTC performs the live phase study {in vivo) and collects samples for CPAC to perform the kinetics. Both of these core leaders are directly involved in study design prior to project initiation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA082709-15
Application #
8781061
Study Section
Subcommittee G - Education (NCI)
Project Start
1999-09-22
Project End
2019-08-31
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
15
Fiscal Year
2014
Total Cost
$35,742
Indirect Cost
$15,953
Name
Indiana University-Purdue University at Indianapolis
Department
Type
DUNS #
603007902
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Broxmeyer, Hal E; Pelus, Louis M (2014) Inhibition of DPP4/CD26 and dmPGE? treatment enhances engraftment of mouse bone marrow hematopoietic stem cells. Blood Cells Mol Dis 53:34-8
Blue, Emily K; DiGiuseppe, Robert; Derr-Yellin, Ethel et al. (2014) Gestational diabetes induces alterations in the function of neonatal endothelial colony-forming cells. Pediatr Res 75:266-72
Miller, Kathy D; Althouse, Sandra K; Nabell, Lisle et al. (2014) A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: translational breast cancer research consortium trial 007. Breast Cancer Res Treat 148:99-106
Chiorean, E Gabriela; Schneider, Bryan P; Akisik, Fatih M et al. (2014) Phase 1 pharmacogenetic and pharmacodynamic study of sorafenib with concurrent radiation therapy and gemcitabine in locally advanced unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 89:284-91
Nudelman, Kelly N H; Wang, Yang; McDonald, Brenna C et al. (2014) Altered cerebral blood flow one month after systemic chemotherapy for breast cancer: a prospective study using pulsed arterial spin labeling MRI perfusion. PLoS One 9:e96713
Hocevar, Barbara A; Kamendulis, Lisa M; Pu, Xinzhu et al. (2014) Contribution of environment and genetics to pancreatic cancer susceptibility. PLoS One 9:e90052
Chitteti, Brahmananda Reddy; Kobayashi, Michihiro; Cheng, Yinghua et al. (2014) CD166 regulates human and murine hematopoietic stem cells and the hematopoietic niche. Blood 124:519-29
Chitteti, Brahmananda Reddy; Srour, Edward F (2014) Cell cycle measurement of mouse hematopoietic stem/progenitor cells. Methods Mol Biol 1185:65-78
Chang, Hua-Chen; Lewis, David; Tung, Chun-Yu et al. (2014) Soypeptide lunasin in cytokine immunotherapy for lymphoma. Cancer Immunol Immunother 63:283-95
Speth, Jennifer M; Hoggatt, Jonathan; Singh, Pratibha et al. (2014) Pharmacologic increase in HIF1* enhances hematopoietic stem and progenitor homing and engraftment. Blood 123:203-7

Showing the most recent 10 out of 83 publications